A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Clinical trial NCT00321464 · COMPLETED

Trial details

NCT number: NCT00321464
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bone Metastases

Start date: 2006-04-01
Primary completion: 2009-07-20
Enrollment: 2049

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.